Skip to content

A study of the pathogenesis and diagnostic, and therapeutic interventions for perinatal depression

A study of the pathogenesis and diagnostic, and therapeutic interventions for perinatal depression

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121679
Enrollment
Unknown
Registered
2026-04-01
Start date
2024-11-27
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perinatal depression

Interventions

intervention group:Internet-based cognitive behavior therapy
control group:health education+treatment as usual

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. PND group: a) Diagnosed and evaluated using the Structured Clinical Interview for DSM-5 Disorders (SCID-5), meeting the criteria for current major depressive episode; b) HAMD-17 >= 14 points and YMRS = 28 weeks) or within 1 year postpartum; e) Han ethnicity, able to understand and communicate in the language required for the study; f) Voluntarily participate in the study and sign a written informed consent form. 2. High-risk group: a) Edinburgh Postnatal Depression Scale score between 9 and 13 (exclusive), and not meeting the SCID criteria for current major depressive episode; b) Meeting any one of the following: history of perinatal/non-perinatal depression or anxiety; history of pregnancy complications or adverse pregnancy outcomes; discontinuation of antidepressants within the past year; history of childhood abuse; or high-risk pregnant women predicted by the onset prediction model; c) Aged 18-45 years; d) Currently in pregnancy (gestational age = 28 weeks) or within 1 year postpartum; e) Han ethnicity, able to understand and communicate in the language required for the study; f) Voluntarily participate in the study and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: a) Current or past history of schizophrenia, bipolar disorder, etc. (anxiety disorder spectrum is not excluded); b) History of neurological diseases or major physical illnesses (such as thyroid disease, lupus erythematosus, diabetes, lung, liver or kidney damage, infections, major trauma, glaucoma, etc.); or history of substance use disorders; c) Patients with clear current suicide plans and/or suicide attempts; d) Other conditions that researchers believe may affect the implementation of the study (such as color blindness, hearing impairment, intellectual disability, etc.).

Design outcomes

Primary

MeasureTime frame
Reduction rate of Hamilton Depression Rating Scale (HAMD);Remission rate of Hamilton Depression Rating Scale (HAMD);Reduction rate of Hamilton Anxiety Rating Scale (HAMA);Remission rate of Hamilton Anxiety Rating Scale (HAMA);

Secondary

MeasureTime frame
HAMD scoring;HAMA scoring;GAD-7 Score;PHQ-9 Score;EPDS Score;PSS Score;PSQI Score;PDQ-D Score;GSRS Score;RRS Score;CD-RISC Score;CTQ Score;DAS Score;BFQ Score;FAD Score;Dietary Habits Questionnaire;cognitive;

Countries

China

Contacts

Public ContactYan Zhang

The Second Xiangya Hospital of Central South University

yan.zhang@csu.ed.cn+86 138 0731 5182

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026